Title: 2025-2026 Regular Session HR 164 PN 1220 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN1220
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 164 PN 1220 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1220 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.164 Session of 2025 INTRODUCED BY GAYDOS, WAXMAN, REICHARD, PUGH, VENKAT, McNEILL, NEILSON, GUZMAN, STEELE, ZIMMERMAN, RIVERA AND CONKLIN, APRIL 1, 2025 REFERRED TO COMMITTEE ON HEALTH, APRIL 1, 2025 A RESOLUTIONRecognizing the month of April 2025 as "Parkinson's Disease Awareness Month" in Pennsylvania.WHEREAS, Parkinson's disease is the second most common progressive neurodegenerative disorder after Alzheimer's disease; andWHEREAS, Parkinson's disease is estimated to affect approximately 1 million people in the United States and the prevalence will rise to 1.2 million by 2030; andWHEREAS, According to the Centers for Disease Control and Prevention, Parkinson's disease is the 14th leading cause of death in the United States; andWHEREAS, Life expectancy is reduced for all onset ages, with disease progression leading to severe disability and possible confinement to a wheelchair or bed prior to death; andWHEREAS, The symptoms of Parkinson's disease vary from person to person and can include asymmetric tremors, slowness of movement and rigidity, difficulty with balance, swallowing, 1234567891011121314151617 chewing and speaking, cognitive impairment and dementia, mood disorders and a variety of other nonmotor symptoms; andWHEREAS, It is estimated that the economic burden of Parkinson's disease is $52 billion annually to patients and family members, including direct and indirect costs, treatment, Social Security payments and lost income; andWHEREAS, While research suggests the cause of Parkinson's disease is a combination of genetic and environmental factors, the exact cause and progression of the disease is still unknown; andWHEREAS, There is no objective test or biomarker for Parkinson's disease, and there is no cure or drug to slow or halt the progression of the disease; andWHEREAS, The National Parkinson's Foundation and the Michael J. Fox Foundation for Parkinson's Research, along with many volunteers, researchers, caregivers and medical professionals, are working to improve the quality of life of individuals living with Parkinson's disease and their families and to further promote Parkinson's disease awareness, education, knowledge, treatment and research; andWHEREAS, Further efforts in research, testing and education are crucial in order to advance toward improved early detection methods, the discovery of more effective treatments to stop the progression of Parkinson's disease and, ultimately, to find a cure for this devastating disease; therefore be itRESOLVED, That the House of Representatives recognize the month of April 2025 as "Parkinson's Disease Awareness Month" in Pennsylvania; and be it furtherRESOLVED, That the House of Representatives urge all residents to support the search for a cure and assist those 20250HR0164PN1220 - 2 - 123456789101112131415161718192021222324252627282930 individuals and families who deal with this debilitating disease.20250HR0164PN1220 - 3 - 12


================================================================================

Raw Text:
2025-2026 Regular Session HR 164 PN 1220 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1220 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.164 Session of 2025 INTRODUCED BY GAYDOS, WAXMAN, REICHARD, PUGH, VENKAT, McNEILL, NEILSON, GUZMAN, STEELE, ZIMMERMAN, RIVERA AND CONKLIN, APRIL 1, 2025 REFERRED TO COMMITTEE ON HEALTH, APRIL 1, 2025 A RESOLUTIONRecognizing the month of April 2025 as "Parkinson's Disease Awareness Month" in Pennsylvania.WHEREAS, Parkinson's disease is the second most common progressive neurodegenerative disorder after Alzheimer's disease; andWHEREAS, Parkinson's disease is estimated to affect approximately 1 million people in the United States and the prevalence will rise to 1.2 million by 2030; andWHEREAS, According to the Centers for Disease Control and Prevention, Parkinson's disease is the 14th leading cause of death in the United States; andWHEREAS, Life expectancy is reduced for all onset ages, with disease progression leading to severe disability and possible confinement to a wheelchair or bed prior to death; andWHEREAS, The symptoms of Parkinson's disease vary from person to person and can include asymmetric tremors, slowness of movement and rigidity, difficulty with balance, swallowing, 1234567891011121314151617 chewing and speaking, cognitive impairment and dementia, mood disorders and a variety of other nonmotor symptoms; andWHEREAS, It is estimated that the economic burden of Parkinson's disease is $52 billion annually to patients and family members, including direct and indirect costs, treatment, Social Security payments and lost income; andWHEREAS, While research suggests the cause of Parkinson's disease is a combination of genetic and environmental factors, the exact cause and progression of the disease is still unknown; andWHEREAS, There is no objective test or biomarker for Parkinson's disease, and there is no cure or drug to slow or halt the progression of the disease; andWHEREAS, The National Parkinson's Foundation and the Michael J. Fox Foundation for Parkinson's Research, along with many volunteers, researchers, caregivers and medical professionals, are working to improve the quality of life of individuals living with Parkinson's disease and their families and to further promote Parkinson's disease awareness, education, knowledge, treatment and research; andWHEREAS, Further efforts in research, testing and education are crucial in order to advance toward improved early detection methods, the discovery of more effective treatments to stop the progression of Parkinson's disease and, ultimately, to find a cure for this devastating disease; therefore be itRESOLVED, That the House of Representatives recognize the month of April 2025 as "Parkinson's Disease Awareness Month" in Pennsylvania; and be it furtherRESOLVED, That the House of Representatives urge all residents to support the search for a cure and assist those 20250HR0164PN1220 - 2 - 123456789101112131415161718192021222324252627282930 individuals and families who deal with this debilitating disease.20250HR0164PN1220 - 3 - 12